Another issue deserving further investigation is the possible integration of COPZ1 targeting with standard cancer treatment; it would be important to assess if COPZ1 targeting might enhance the sensitivity of cancer cells to conventional therapeutic agents. Here, COPZ1 is linked to cancer.